Fentiapril is a sulfhydryl-containing angiotensin-converting enzyme (ACE) inhibitor that was investigated in the 1980s as a potential medication for managing hypertension (high blood pressure) and reducing the workload on the heart. Like other sulfhydryl-containing ACE inhibitors, it functions as a effective free radical scavenger. It is grouped under the following drug class(es): ACE Inhibitors. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Rentiapril and Prescrin. Its PubChem CID is 71244.
Fentiapril
| CAS No | 80830-42-8 |
|---|---|
| Molecular Formula | C13H15NO4S2 |
| Molecular Weight | 313.4 g/mol |
| Synonyms | (2R,4R)-2-(2-hydroxyphenyl)-3-(3-sulfanylpropanoyl)-1,3-thiazolidine-4-carboxylic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Fentiapril is a sulfhydryl-containing angiotensin-converting enzyme (ACE) inhibitor that was investigated in the 1980s as a potential medication for managing hypertension (high blood pressure) and reducing the workload on the heart.
The listed CAS number is 80830-42-8.
The listed molecular formula is C13H15NO4S2.
The listed molecular weight is 313.4 g/mol.
(2R,4R)-2-(2-hydroxyphenyl)-3-(3-sulfanylpropanoyl)-1,3-thiazolidine-4-carboxylic acid.
The source lists Rentiapril and Prescrin.